Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care

BMC Family Practice

Volumn 9, Issue , 2008, Pages

  Koschack, Janka ^a   Scherer, Martin ^a   Lüers, Claus ^a   Kochen, Michael M ^a   Wetzel, Dirk ^a   Kleta, Sibylle ^a   Pouwels, Claudia ^a   Wachter, Rolf ^a   Herrmann Lingen, Christoph ^a   Pieske, Burkert ^a   Binder, Lutz ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; DIURETIC AGENT; BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CORONARY ARTERY DISEASE; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; DIURETIC THERAPY; DYSPNEA; ECHOCARDIOGRAPHY; EVALUATION; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE CONTRACTION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MCNEMAR TEST; MEDICAL INFORMATION; PRIMARY MEDICAL CARE; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; SWELLING; SYSTOLIC DYSFUNCTION; BLOOD; COMPARATIVE STUDY; ECHOGRAPHY; GERMANY; HEART LEFT VENTRICLE FUNCTION; METHODOLOGY; MIDDLE AGED; PRIMARY HEALTH CARE; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; ROC CURVE; STATISTICAL MODEL;

AGED; ECHOCARDIOGRAPHY; FEMALE; GERMANY; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PRIMARY HEALTH CARE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; VENTRICULAR DYSFUNCTION, LEFT;

EID: 40849119868     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-9-14     Document Type: Article

References (27)

1. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. The SOLVD Investigators, N Engl J Med 1992 327 685 91 1463530
2. Can the clinical examination diagnose left-sided heart failure in adults? RG Badgett CR Lucey CD Mulrow, JAMA 1997 277 1712 9 10.1001/jama.277.21.1712 9169900
3. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). SA Hunt WT Abraham MH Chin AM Feldman GS Francis TG Ganiats M Jessup MA Konstam DM Mancini K Michl JA Oates PS Rahko MA Silver LW Stevenson CW Yancy EM Antman SC Smith Jr CD Adams JL Anderson DP Faxon V Fuster JL Halperin LF Hiratzka AK Jacobs R Nishimura JP Ornato RL Page B Riegel American College of Cardiology; American Heart Association Task Force on Practice Guidelines; American College of Chest Physicians; International Society for Heart and Lung Transplantation; Heart Rhythm Society, Circulation 2005 112 e154 e235 10.1161/CIRCULATIONAHA.105.167586 16160202
4. European survey of primary care physician perceptions on heart failure diagnosis and management (EURO-HF). FDR Hobbs MI Jones TF Allan S Wilson R Tobias, Eur Heart J 2000 21 1877 87 10.1053/euhj.2000.2170 11052861
5. Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. OW Nielsen TA McDonagh SD Robb HJ Dargie, JACC 2003 41 113 20 12570953
6. Diagnostic and prognostic evaluation of left ventricular systolic heart failure by plasma N-terminal pro-brain natriuretic peptide concentrations in a large sample of the general population. BA Groenning I Raymond JC Hildebrandt JC Nilsson M Baumann F Pedersen, Heart 2004 90 297 303 14966052 10.1136/hrt.2003.026021
7. Diagnostic and prognostic performance of NT-terminal proBNP in primary care patients with suspected heart failure. F Gustafsson F Steensgaard-Hansen J Badskjaer AH Poulsen P Corell P Hildebrandt, J Card Fail 2005 11 S15 S20 10.1016/j.cardfail.2005.04.022 15948095
8. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of heart failure. cohort study in representative and high risk community populations. FDR Hobbs RC Davis AK Roalfe R Hare MK Davies AK Kenkre, BMJ 2002 324 1 5 11777781 10.1136/bmj.324.7352.1498
9. Cohort study of plasma natriuretic peptides for identifying left ventricular systolic dysfunction in primary care. SJ McClure L Caruana AP Davie S Goldthorp JJV McMurray, BMJ 1998 317 516 9 9712601
10. Utility of B-natriuretic peptide in detecting diastolic dysfunction. Comparison with Doppler velocity recordings. E Lubien A DeMaria P Krishnaswamy P Clopton J Koon R Kazanegra N Gardetto E Wanner AS Maisel, Circulation 2002 105 595 601 10.1161/hc0502.103010 11827925
11. Profile for estimating risk of heart failure. WB Kannel RB D'Agostino H Silbershatz AJ Belanger PWF Wilson D Levy, Arch Intern Med 1999 159 1197 204 10.1001/archinte.159.11.1197 10371227
12. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. JA Hanley BJ McNeil, Radiology 1983 148 839 43 6878708
13. The architecture of diagnostic research. DL Sackett RB Haynes, BMJ 2002 324 539 41 11872558 10.1136/bmj.324.7336.539
14. Ruling a diagnosis in or out with "SpPIn" and "SnNOut": a note of caution. D Pewsner M Battaglia C Minder H Marx HC Bucher M Egger, BMJ 2004 329 209 13 15271832 10.1136/bmj.329.7459.209
15. Accuracy of B-type natriuretic peptide tests to exclude congestive heart failure. Systematic review of test accuracy studies. M Battaglia D Pewsner P Jüni M Egger HC Bucher LM Bachmann, Arch Intern Med 2006 166 1073 80 10.1001/archinte.166.10.1073 16717169
16. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. JA Doust P Glasziou E Pietrzak A Dobsen, Arch Intern 2004 164 18 1978 1984 10.1001/archinte.164.18.1978 15477431
17. Estimating prognosis in heart failure: time for a better approach. MR Cowie, Heart 2003 89 587 8 12748203 10.1136/heart.89.6.587
18. Do patients with suspected heart failure and preserved left ventricular systolic function suffer from "diastolic heart failure" or from misdiagnosis? A prospective descriptive study. L Caruana MC Petrie JJV McMurray, BMJ 2000 321 215 8 10903655 10.1136/bmj.321.7255.215
19. Poor concordance of commonly used echocardiographic measures of left ventricular diastolic dysfunction in patients with suspected heart failure but preserved systolic function: is there a reliable echocardiographic measure of diastolic dysfunction? MC Petrie K Hogg L Caruana JJV McMurray, Heart 2004 90 511 7 15084546 10.1136/hrt.2003.011403
20. Risk assessment of left ventricularsystolic dysfunction in primary care: cross sectional study evaluating a range of diagnostic tests. OW Nielsen JF Hansen J Hilden CT Larsen J Svanegaard, BMJ 2000 320 220 4 10642232 10.1136/bmj.320.7229.220
21. Prevalence of impaired left ventricular systolic function and heart failure in a middle aged and elderly urban population segment of Copenhagen. I Raymond F Pedersen F Steensgaard-Hansen A Green M Busch-Sorensen C Tuxen J Appel J Jacobsen D Atar P Hildebrandt, Heart 2003 89 1422 9 14617553 10.1136/heart.89.12.1422
22. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. D Pewsner P Jüni M Egger M Battaglia J Sundström LM Bachmann, BMJ 2007 335 711 17726091 10.1136/bmj.39276.636354.AE
23. Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. PA Heidenreich MA Gubens GC Fonarow MA Konstam LW Stevenson PG Shekelle, JACC 2004 43 1019 26 15028361
24. Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis. C Davenport EY Cheng YT Kwok AH Lai T Wakabayashi C Hyde M Connock, Br J Gen Pract 2006 56 48 56 16438815
25. Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study. MJ Landray R Lehman I Arnold, BMJ 2000 320 985 6 10753153 10.1136/bmj.320.7240.985
26. Concept and usefulness of cardiovascular risk profiles. WB Kannel RB D'Agostino L Sullivan PWF Wilson, Am Heart J 2004 148 16 26 10.1016/j.ahj.2003. 10.022 15215787
27. Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure. JH Rutten F Boomsma AH Van den Meiracker, Ned Tijdschr Geneeskd 2007 151 2553 7 18074722